C. Astori

1.6k total citations
22 papers, 1.1k citations indexed

About

C. Astori is a scholar working on Hematology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, C. Astori has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 9 papers in Pathology and Forensic Medicine and 5 papers in Molecular Biology. Recurrent topics in C. Astori's work include Acute Myeloid Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (4 papers). C. Astori is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (4 papers). C. Astori collaborates with scholars based in Italy, Israel and United States. C. Astori's co-authors include Emanuela Boveri, Mario Lazzarino, Daniela Pietra, Luca Arcaini, Ercole Brusamolino, Chiara Elena, Francesco Passamonti, Sabrina Boggi, Enrica Morra and Elisa Roncoroni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

C. Astori

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Astori Italy 13 764 574 471 281 260 22 1.1k
Cesare Astori Italy 14 735 1.0× 497 0.9× 472 1.0× 237 0.8× 224 0.9× 29 1.0k
Eva Löfvenberg Sweden 18 813 1.1× 988 1.7× 362 0.8× 166 0.6× 229 0.9× 32 1.4k
Maura Nicolosi Italy 14 646 0.8× 533 0.9× 341 0.7× 192 0.7× 273 1.1× 35 933
Carlos Besses Spain 22 1.4k 1.8× 919 1.6× 845 1.8× 525 1.9× 227 0.9× 78 1.8k
Michele Merli Italy 17 705 0.9× 286 0.5× 303 0.6× 175 0.6× 474 1.8× 64 1.1k
Claire Dearden United Kingdom 9 531 0.7× 378 0.7× 157 0.3× 273 1.0× 369 1.4× 16 947
Ester Pungolino Italy 16 1.6k 2.1× 1.4k 2.5× 864 1.8× 538 1.9× 196 0.8× 39 2.0k
Rakhee Vaidya United States 13 1.6k 2.2× 1.3k 2.2× 897 1.9× 625 2.2× 282 1.1× 43 2.1k
Kamel Laribi France 17 321 0.4× 604 1.1× 336 0.7× 54 0.2× 329 1.3× 62 1.2k
R Ayats Spain 11 590 0.8× 237 0.4× 180 0.4× 76 0.3× 282 1.1× 23 742

Countries citing papers authored by C. Astori

Since Specialization
Citations

This map shows the geographic impact of C. Astori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Astori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Astori more than expected).

Fields of papers citing papers by C. Astori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Astori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Astori. The network helps show where C. Astori may publish in the future.

Co-authorship network of co-authors of C. Astori

This figure shows the co-authorship network connecting the top 25 collaborators of C. Astori. A scholar is included among the top collaborators of C. Astori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Astori. C. Astori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pietra, Daniela, Elisa Rumi, Virginia Valeria Ferretti, et al.. (2015). Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms. Leukemia. 30(2). 431–438. 178 indexed citations
2.
3.
Rumi, Elisa, Francesco Passamonti, Chiara Elena, et al.. (2010). Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. Haematologica. 96(3). 454–458. 40 indexed citations
4.
Passamonti, Francesco, Elisa Rumi, Luca Arcaini, et al.. (2008). Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients. Haematologica. 93(11). 1645–1651. 177 indexed citations
5.
Corso, Alessandro, Silvia Mangiacavalli, Annamaria Nosari, et al.. (2005). Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma. Bone Marrow Transplantation. 36(11). 951–954. 5 indexed citations
6.
7.
Bernasconi, Paolo, Paola Maria Cavigliano, Marina Boni, et al.. (2000). Trisomy 11 and a Complex t(11;11;22) in a Patient with Acute Myelomonocytic Leukemia (AML-M4) Following Myelodysplasia (MDS). Cancer Genetics and Cytogenetics. 116(2). 111–118. 4 indexed citations
8.
Lazzarino, Mario, Ester Orlandi, Marco Montillo, et al.. (1999). Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma. Annals of Oncology. 10(1). 59–64. 34 indexed citations
9.
Corso, Alessandro, C. Astori, Ester Orlandi, et al.. (1999). Transient response of myeloma clone to pamidronate therapy.. PubMed. 84(8). 759–60. 11 indexed citations
10.
Bernasconi, Paolo, Paola Maria Cavigliano, Emilia Genini, et al.. (1998). A Complex Translocation (5;7) in a Patient with Acute Nonlymphocytic Leukemia Evolved from a Myelodysplastic Syndrome. Cancer Genetics and Cytogenetics. 105(2). 182–186. 1 indexed citations
11.
Orlandi, Ester, Mario Lazzarino, Paolo Bernasconi, C. Astori, & Carlo Bernasconi. (1998). Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.. PubMed. 83(8). 758–9. 7 indexed citations
12.
Bonfichi, Maurizio, et al.. (1997). Growth Factors in the Therapy of Myelodisplasia: Biological Aspects. Leukemia & lymphoma. 26(sup1). 35–40. 7 indexed citations
13.
Merante, Serena, C. Astori, Paolo Bernasconi, et al.. (1995). Chronic myelogenous leukemia and exposure to ionizing radiation ? a retrospective study of 443 patients. Annals of Hematology. 70(2). 79–82. 2 indexed citations
14.
Castagnola, Carlo, et al.. (1995). Acute Myeloid Leukemia and Diabetes insipidus: Results in 5 Patients. Acta Haematologica. 93(1). 1–4. 18 indexed citations
15.
Corso, Alessandro, Mario Lazzarino, Enrica Morra, et al.. (1995). Chronic myelogenous leukemia and exposure to ionizing radiation — a retrospective study of 443 patients. Annals of Hematology. 70(2). 79–82. 19 indexed citations
16.
Brusamolino, Ercole, Ester Orlandi, Enrica Morra, et al.. (1994). Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy. Annals of Oncology. 5. S53–S57. 31 indexed citations
17.
Brusamolino, Ercole, Ester Orlandi, A Canevari, et al.. (1994). Results of CAV regimen (CCNU, Melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease. Annals of Oncology. 5(5). 427–432. 20 indexed citations
18.
Bernasconi, Paolo, E. P. Alessandrino, Marina Boni, et al.. (1994). Karyotype in myelodysplastic syndromes: Relations to morphology, clinical evolution, and survival. American Journal of Hematology. 46(4). 270–277. 37 indexed citations
19.
Brusamolino, Ercole, Mario Lazzarino, Ester Orlandi, et al.. (1994). Early-stage Hodgkin's disease: Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy. Annals of Oncology. 5. S101–S106. 41 indexed citations
20.
Lazzarino, Mario, Ester Orlandi, Marco Paulli, et al.. (1993). Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features.. Journal of Clinical Oncology. 11(12). 2306–2313. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cesare Astori Breakdown of academic impact, for papers by Eva Löfvenberg Breakdown of academic impact, for papers by Maura Nicolosi Breakdown of academic impact, for papers by Carlos Besses Breakdown of academic impact, for papers by Michele Merli Breakdown of academic impact, for papers by Claire Dearden Breakdown of academic impact, for papers by Ester Pungolino Breakdown of academic impact, for papers by Rakhee Vaidya Breakdown of academic impact, for papers by Kamel Laribi Breakdown of academic impact, for papers by R Ayats
Rankless by CCL
2026